MSB 7.69% $1.19 mesoblast limited

FDA ODAC Meeting Material discussion analysis, page-335

  1. 5,481 Posts.
    lightbulb Created with Sketch. 8927
    I’m not talking about manufacturing - I’m talking about the trial results.

    the FDA don’t believe the trial is well designed and stated their reasons for that.. single arm, past trial data, how they came up with the null hypothesis
    Last edited by stockrock: 13/08/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.